🇺🇸 Metformin hydrochoride in United States

9 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 9

Most-reported reactions

1. Abdominal Pain Upper — 1 report (11.11%)
2. Apolipoprotein A-I Decreased — 1 report (11.11%)
3. Blood Pressure Increased — 1 report (11.11%)
4. Diabetes Mellitus Inadequate Control — 1 report (11.11%)
5. Gastrointestinal Haemorrhage — 1 report (11.11%)
6. Glycosylated Haemoglobin Increased — 1 report (11.11%)
7. High Density Lipoprotein Decreased — 1 report (11.11%)
8. Intestinal Obstruction — 1 report (11.11%)
9. Myocardial Ischaemia — 1 report (11.11%)

Source database →

Frequently asked questions

Is Metformin hydrochoride approved in United States?

Metformin hydrochoride does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Metformin hydrochoride in United States?

University of Massachusetts, Worcester is the originator. The local marketing authorisation holder may differ — check the official source linked above.